Analyzing Standard Lithium (NYSE:SLI) & Koninklijke DSM (OTCMKTS:RDSMY)

Standard Lithium (NYSE:SLI) and Koninklijke DSM (OTCMKTS:RDSMY) are both oils/energy companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, profitability, valuation, earnings, risk and institutional ownership.

Dividends

Standard Lithium pays an annual dividend of $2.00 per share and has a dividend yield of 122.7%. Koninklijke DSM pays an annual dividend of $0.37 per share and has a dividend yield of 1.1%. Standard Lithium pays out -869.6% of its earnings in the form of a dividend.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Standard Lithium and Koninklijke DSM, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Standard Lithium	0	0	1	0	3.00
Koninklijke DSM	0	0	0	0	N/A

Standard Lithium currently has a consensus target price of $3.50, indicating a potential upside of 114.72%. Given Standard Lithium’s higher possible upside, research analysts clearly believe Standard Lithium is more favorable than Koninklijke DSM.

Insider and Institutional Ownership

16.8% of Standard Lithium shares are held by institutional investors. Comparatively, 0.2% of Koninklijke DSM shares are held by institutional investors. 3.7% of Standard Lithium shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Standard Lithium and Koninklijke DSM’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Standard Lithium	N/A	-15.67%	-14.05%
Koninklijke DSM	N/A	N/A	N/A

Risk & Volatility

Standard Lithium has a beta of 1.89, suggesting that its share price is 89% more volatile than the S&P 500. Comparatively, Koninklijke DSM has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.

Earnings and Valuation

This table compares Standard Lithium and Koninklijke DSM”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Standard Lithium	N/A	N/A	-$31.35 million	($0.23)	-7.09
Koninklijke DSM	$10.89 billion	2.17	$1.98 billion	N/A	N/A

Koninklijke DSM has higher revenue and earnings than Standard Lithium.

Summary

Standard Lithium beats Koninklijke DSM on 7 of the 11 factors compared between the two stocks.

About Standard Lithium

Standard Lithium Ltd. explores for, develops, and processes lithium brine properties in the United States. Its flagship project is the Lanxess project with area of approximately 150,000 acres located in southern Arkansas. The company was formerly known as Patriot Petroleum Corp. and changed its name to Standard Lithium Ltd. in December 2016. Standard Lithium Ltd. was incorporated in 1998 and is headquartered in Vancouver, Canada.

About Koninklijke DSM

Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and sustainable living businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Nutrition, Materials, and Innovation Center segments. The Nutrition segment offers animal nutrition and health products, including vitamins, premixes, carotenoids, enzymes, microbes, and eubiotics; human nutrition and health products comprising vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics, and prebiotics, as well as active pharmaceutical ingredients; premix, market-ready solutions, and personalized nutrition; human milk oligosaccharides; and skin and sun care, hair care, and aroma ingredients; omega-3 fatty acids; and specialty food enzymes, cultures, bio-preservation, texturizing hydrocolloids, sugar reduction, and savory taste solutions. The Materials segment provides specialty plastics used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries; and Dyneema, a fiber solution for use in personal protection, workwear, sports apparel, outdoor equipment, ropes and slings, synthetic chains, and nets for the aquaculture, and renewable energy sectors. The Innovation Center segment offers biomedical materials, and medical device and material manufacturing technologies in the areas of cardiovascular, continence care, dental, diabetes management, gynecology, neurology, ophthalmology, orthopedic, peripheral vascular, plastic and reconstructive surgery, and wound management. It also commercializes yeast technology yeast for ethanol production. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.